Healthcare costs seem to have increased for cancer patients amid the ongoing coronavirus situation, since these patients are at the high risk of contracting the infection, owing to low immunity levels. This has created revenue opportunities for companies in the hyperthermia cancer treatment market, as clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care.
Hospitals and specialty clinics are increasing their investments in developing special screening departments for the evaluation of cancer patients with potential COVID-19 symptoms. Such trends are generating business streams in order to revive growth of the hyperthermia cancer treatment market. However, many clinics have limited and even excluded the amount of visitors that are at the low risk of COVID-19.
Companies in the hyperthermia cancer treatment market are increasing their R&D in new treatment options for patients. This has led to the emergence of glass ceramics for hyperthermia techniques, owing to their advantages of biocompatibility, bioactivity, and osteoproductivity. However, scientists are yet to explore ways to prevent the occurrence of undesired crystalline phases in the material. Companies are partnering with researchers and scientists to prevent the magnetite oxidation to hematite, which can emerge, while undergoing the heat treatment.
The hyperthermia cancer treatment market is slated to register a favorable CAGR of ~6% during the forecast period. This is evident since glass ceramics in hyperthermia techniques are capable of raising the temperature of cancerous tissues high enough to destroy it.
The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.
The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.
High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.
Combination treatments such as hyperthermia with chemotherapy via controlled localized heating can be achieved with the help of radiofrequency (RF) and microwave. Recent advancements in radiofrequency and microwave mediated hyperthermia include applicators that are most suitable for superficial hyperthermia. On the other hand, internal heating or deep hyperthermia is being combined with brachytherapy i.e. a needle-shaped antenna/electrode that can be implanted directly in the tissue or inserted via catheters.
The high variety in applicator designs for internal heating such as microwave antennas, capacitive-coupled RF catheter-based electrodes, and ultrasound systems are creating value grab opportunities for companies in the hyperthermia cancer treatment market. Med-tech companies are gaining a strong research in operating principles of internal heating techniques and other devices.
Analysts’ Viewpoint
Telemedicine and mobile apps are offering wellness and stress management resources to cancer patients amid the ongoing COVID-19 pandemic. Companies in the hyperthermia cancer treatment market are benefitting with the help of the deep tissue thermal therapy, owing to its non-invasive nature that omits the need of anesthesia. However, radiation dose weighting-based on clonogenic cell survival analysis alone may not be sufficient to predict treatment efficacy. Hence, companies in the hyperthermia cancer treatment market should increase their R&D in more sophisticated biological dose concepts based on spheroid data to improve patient outcomes. Glass ceramics are a breakthrough innovation in the hyperthermia cancer treatment that hold promising potentials with advancements in biomaterial R&D.
Hyperthermia cancer treatment market to cross valuation of US$ 266 Mn by 2030
Hyperthermia cancer treatment market is projected to expand at a CAGR of ~6% from 2020 to 2030
Hyperthermia cancer treatment market is driven by rise in prevalence and incidence of cancers
The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period
Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Hyperthermia Cancer Treatment Market Forecast
4.4. Global Hyperthermia Cancer Treatment Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Epidemiology of Cancer Globally/Country
5.3. Reimbursement Scenario
5.4. Regulatory Scenario
5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia
6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type
6.1. Introduction
6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type
6.3.1. Infrared Hyperthermia Devices
6.3.2. Ultrasound Hyperthermia Devices
6.3.3. Microwave Hyperthermia Devices
6.3.4. Others
6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type
7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
7.1. Introduction
7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
7.3.1. Locoregional
7.3.1.1. External & Interstitial
7.3.1.2. Intraluminal or Endocavitary Methods
7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
7.3.1.4. Deep Tissue & Regional Perfusion
7.3.2. Whole-body
7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
8. Global Hyperthermia Cancer Treatment Market Analysis, by Application
8.1. Introduction
8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application
8.3.1. Breast Cancer
8.3.2. Liver Cancer
8.3.3. Soft Tissue Sarcoma
8.3.4. Head & Neck Tumors
8.3.5. Prostate Cancer
8.3.6. Others
8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application
9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user
9.1. Introduction
9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user
9.3.1. Hospitals & Specialty Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user
10. Global Hyperthermia Cancer Treatment Market Analysis, by Region
10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country
10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region
10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Hyperthermia Cancer Treatment Market Analysis
11.1. North America Hyperthermia Cancer Treatment Market Overview
11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country
11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type
11.5.1. Infrared Hyperthermia Devices
11.5.2. Ultrasound Hyperthermia Devices
11.5.3. Microwave Hyperthermia Devices
11.5.4. Others
11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
11.7.1. Locoregional
11.7.1.1. External & Interstitial
11.7.1.2. Intraluminal or Endocavitary Methods
11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
11.7.1.4. Deep Tissue & Regional Perfusion
11.7.2. Whole-body
11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application
11.9.1. Breast Cancer
11.9.2. Liver Cancer
11.9.3. Soft Tissue Sarcoma
11.9.4. Head & Neck Tumors
11.9.5. Prostate Cancer
11.9.6. Others
11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user
11.11.1. Hospitals & Specialty Clinics
11.11.2. Ambulatory Surgical Centers
11.11.3. Others
12. Europe Hyperthermia Cancer Treatment Market Analysis
12.1. Europe Hyperthermia Cancer Treatment Market Overview
12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type
12.5.1. Infrared Hyperthermia Devices
12.5.2. Ultrasound Hyperthermia Devices
12.5.3. Microwave Hyperthermia Devices
12.5.4. Others
12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
12.7.1. Locoregional
12.7.1.1. External & Interstitial
12.7.1.2. Intraluminal or Endocavitary Methods
12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
12.7.1.4. Deep Tissue & Regional Perfusion
12.7.2. Whole-body
12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application
12.9.1. Breast Cancer
12.9.2. Liver Cancer
12.9.3. Soft Tissue Sarcoma
12.9.4. Head & Neck Tumors
12.9.5. Prostate Cancer
12.9.6. Others
12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user
12.11.1. Hospitals & Specialty Clinics
12.11.2. Ambulatory Surgical Centers
12.11.3. Others
13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis
13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview
13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
13.3.1. Japan
13.3.2. China
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type
13.5.1. Infrared Hyperthermia Devices
13.5.2. Ultrasound Hyperthermia Devices
13.5.3. Microwave Hyperthermia Devices
13.5.4. Others
13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
13.7.1. Locoregional
13.7.1.1. External & Interstitial
13.7.1.2. Intraluminal or Endocavitary Methods
13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
13.7.1.4. Deep Tissue & Regional Perfusion
13.7.2. Whole-body
13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application
13.9.1. Breast Cancer
13.9.2. Liver Cancer
13.9.3. Soft Tissue Sarcoma
13.9.4. Head & Neck Tumors
13.9.5. Prostate Cancer
13.9.6. Others
13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user
13.11.1. Hospitals & Specialty Clinics
13.11.2. Ambulatory Surgical Centers
13.11.3. Others
14. Latin America Hyperthermia Cancer Treatment Market Analysis
14.1. Latin America Hyperthermia Cancer Treatment Market Overview
14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type
14.5.1. Infrared Hyperthermia Devices
14.5.2. Ultrasound Hyperthermia Devices
14.5.3. Microwave Hyperthermia Devices
14.5.4. Others
14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
14.7.1. Locoregional
14.7.1.1. External & Interstitial
14.7.1.2. Intraluminal or Endocavitary Methods
14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
14.7.1.4. Deep Tissue & Regional Perfusion
14.7.2. Whole-body
14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application
14.9.1. Breast Cancer
14.9.2. Liver Cancer
14.9.3. Soft Tissue Sarcoma
14.9.4. Head & Neck Tumors
14.9.5. Prostate Cancer
14.9.6. Others
14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user
14.11.1. Hospitals & Specialty Clinics
14.11.2. Ambulatory Surgical Centers
14.11.3. Others
15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis
15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview
15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type
15.5.1. Infrared Hyperthermia Devices
15.5.2. Ultrasound Hyperthermia Devices
15.5.3. Microwave Hyperthermia Devices
15.5.4. Others
15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
15.7.1. Locoregional
15.7.1.1. External & Interstitial
15.7.1.2. Intraluminal or Endocavitary Methods
15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
15.7.1.4. Deep Tissue & Regional Perfusion
15.7.2. Whole-body
15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application
15.9.1. Breast Cancer
15.9.2. Liver Cancer
15.9.3. Soft Tissue Sarcoma
15.9.4. Head & Neck Tumors
15.9.5. Prostate Cancer
15.9.6. Others
15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user
15.11.1. Hospitals & Specialty Clinics
15.11.2. Ambulatory Surgical Centers
15.11.3. Others
16. Competition Landscape
16.1. Competition Matrix
16.2. Company Profiles
16.2.1. Pyrexar Medical
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Strategic Overview
16.2.2. Celsius42 GmbH
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. Hydrosun GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Strategic Overview
16.2.4. Oncotherm Kft
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Strategic Overview
16.2.5. Andromedic S.r.l.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Yamamoto Vinita Co., Ltd.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Strategic Overview
16.2.7. Chongqing Haifu Medical Technology Co., Ltd
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Strategic Overview
16.2.8. innoMedicus Ltd.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Strategic Overview
16.2.9. Gamida
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Strategic Overview
16.2.10. RanD.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Strategic Overview
List of Tables
Table 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030
Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030
Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Hyperthermia Cancer Treatment Market Value Share, by Device Type, 2019
Figure 03: Global Hyperthermia Cancer Treatment Market Value Share, by Treatment Method, 2019
Figure 04: Global Hyperthermia Cancer Treatment Market Value Share, by Application, 2019
Figure 05: Global Hyperthermia Cancer Treatment Market Value Share, by End-user, 2019
Figure 06: Global Hyperthermia Cancer Treatment Market Value Share, by Region, 2019
Figure 07: Global New Cancer Cases & Deaths, 2017
Figure 08: Incidence of Breast Cancer, by Country
Figure 09: Prevalence of Breast Cancer, by Country
Figure 10: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 11: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 12: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Infrared Hyperthermia Devices, 2018–2030
Figure 13: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ultrasound Hyperthermia Devices, 2018–2030
Figure 14: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Microwave Hyperthermia Devices, 2018–2030
Figure 15: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030
Figure 16: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 17: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030
Figure 18: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Locoregional, 2018–2030
Figure 19: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Whole-Body, 2018–2030
Figure 20: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 21: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 22: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Breast Cancer, 2018–2030
Figure 23: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Liver Cancer, 2018–2030
Figure 24: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Soft Tissue Sarcoma, 2018–2030
Figure 25: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Head & Neck Tumors, 2018–2030
Figure 26: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Prostate Cancer, 2018–2030
Figure 27: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030
Figure 28: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 29: Global Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030
Figure 30: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Hospitals & Specialty Clinics, 2018–2030
Figure 31: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2018–2030
Figure 32: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Standalone Devices, 2018–2030
Figure 33: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 34: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Region
Figure 35: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 36: North America Hyperthermia Cancer Treatment Market Value Share (%), by Country, 2019 and 2030
Figure 37: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country, 2020–2030
Figure 38: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 39: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 40: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 41: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–203041
Figure 42: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 43: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 44: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 45: North America Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030
Figure 46: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 47: Europe Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 48: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 49: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 50: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 51: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 52: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030
Figure 53: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 54: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 55: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 56: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030
Figure 57: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 58: Asia Pacific Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 59: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 60: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 61: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 62: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 63: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030
Figure 64: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 65: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 66: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 67: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030
Figure 68: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 69: Latin America Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 70: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 71: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 72: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 73: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 74: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030
Figure 75: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 76: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 77: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 78: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030
Figure 79: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 80: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 81: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 82: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030
Figure 83: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030
Figure 84: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030
Figure 85: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030
Figure 86: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030
Figure 87: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030
Figure 88: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030
Figure 89: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hyperthermia Cancer Treatment Market
